[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Cerami, 2012 - Google Patents

The unexpected pathway to the creation of the HbA1c test and the discovery of AGE's.

Cerami, 2012

View PDF @Full View
Document ID
11765205307780275910
Author
Cerami A
Publication year
Publication venue
Journal of internal medicine

External Links

Snippet

The article focuses on the creation of the HbA1c diagnostic test. It mentions that the HbA1c was measured in a series of patients with diabetes in collaboration with Joe Williamson and found that it is correlated with fasting blood sugar. It adds that the incidence of birth defects …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Similar Documents

Publication Publication Date Title
Twarda-Clapa et al. Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs
Cerami The unexpected pathway to the creation of the HbA1c test and the discovery of AGE's.
Cerami et al. Protein glycosylation and the pathogenesis of atherosclerosis
Lyons et al. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.
Walsh et al. Anaemia during critical illness
Kennedy et al. Non-enzymatically glycosylated serum protein in diabetes mellitus: an index of short-term glycaemia
JPH0667827B2 (en) Maillard reaction inhibitor
Cerami et al. Role of nonenzymatic glycosylation in atherogenesis
Samborski et al. Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes
Bhatwadekar et al. Rapid method for the preparation of an AGE‐BSA standard calibrator using thermal glycation
Maher et al. Latent Biochemical Relationships in the Blood–Milk Metabolic Axis of Dairy Cows Revealed by Statistical Integration of 1H NMR Spectroscopic Data
Gołacki et al. Link between insulin resistance and obesity—from diagnosis to treatment
Luce et al. Is 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a clinically relevant uremic toxin in haemodialysis patients?
Zainal Investigation of antioxidant markers in diabetic patients
Farasat et al. Relationship of Thyroid Hormones with Serum Fasting Insulin and Insulin Resistance in Euthyroid Glycemic Anomalies.
Sakai-Sakasai et al. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite
Siewiera et al. Potential role of mitochondria as modulators of blood platelet activation and reactivity in diabetes and effect of metformin on blood platelet bioenergetics and platelet activation
Karapehlivan et al. Short Communication Serum Sialic Acid Levels in Calves with Pneumonia
Yam et al. Hydroxyethyl starch 130/0.4 (6%) and succinylated gelatine (4%) interfere with refractometry in dogs with haemorrhagic shock
Prasad et al. IgG glycation and diabetes: a review
Witte et al. Analysis of blood gases, serum fat and serum protein: a new approach to estimate survival chances of stranded Harbor seal (Phoca vitulina) pups from the German North Sea
Kereliuk et al. Extracellular vesicles as an index for endothelial injury and cardiac dysfunction in a rodent model of GDM
Hatfield Advanced glycation end-products (AGEs) in hyperglycemic patients
Zalejska-Fiolka et al. Loss of Skeletal Muscle Mass and Intracellular Water as Undesired Outcomes of Weight Reduction in Obese Hyperglycemic Women: A Short-Term Longitudinal Study
Méndez et al. ACETONE, THE THIRD KETONE BODY. II. ACTIONS ON ERYTHROCYTE MEMBRANE AND HEMOGLOBIN IN TOTAL HUMAN BLOOD